about
Pharmacotherapy of Pain in the Older Population: The Place of OpioidsCancer cachexia: impact, mechanisms and emerging treatmentsA Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.Polypharmacy in older adults: the role of the advanced practitioner in oncology.Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.Determining chemotherapy tolerance in older patients with cancer.Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage.How to implement a geriatric assessment in your clinical practiceResearch priorities in geriatric oncology for 2013 and beyond.Treatment of cancer in the older aged person.Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.Cardiovascular complications of breast cancer therapy in older adultsPain Management in the Elderly: An FDA Safe Use Initiative Expert Panel's View on Preventable Harm Associated with NSAID Therapy.Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.Allergic diseases in the elderlyPatient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer.Association of pre-operative medication use with post-operative delirium in surgical oncology patients receiving comprehensive geriatric assessment.Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy.Senior adult oncology.Systemic therapies for metastatic renal cell carcinoma in older adults.Prescribing Patterns and Perceptions of Health Care Professionals About Rational Drug use in a Specialist Hospital ClinicPotential drug interactions in patients with a history of cancer.Use of vitamin and mineral supplements in long-term care home residents.Elderly acute myeloid leukemia: assessing risk.Managing multiple myeloma in elderly patients.Polypharmacy and potentially inappropriate medication use in geriatric oncology.Definition of Unfit for Standard Acute Myeloid Leukemia Therapy.Drug dispensings among elderly in the year before colon cancer diagnosis versus matched cancer-free controls.Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer.Polypharmacy in the terminal stage of cancer.What is polypharmacy? A systematic review of definitions.Polypharmacy in the Geriatric Oncology Population.Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival.Drug Prescription Including Interactions with Anticancer Treatments in the Elderly: A Global Approach.Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.Polypharmacy and patterns of prescription medication use among cancer survivors.Comprehensive geriatric assessment prediction of postoperative complications in gastrointestinal cancer patients: a meta-analysis.
P2860
Q26744640-7FB45877-B513-43F1-9AFD-5DA37405167EQ28384479-9CF1221E-FA1B-43FF-93D8-69DFE04E10C4Q30276856-ECE6A80E-AA76-48A2-95FD-F57F7AC8B9FAQ33885951-3E93DC89-B53A-4D96-8949-6DF1FBE9A984Q34092726-F939D7DA-46F1-4AFA-A6E8-5CFA714ACE9AQ34155010-5580B389-C435-4325-94E2-65F06B98E997Q34276487-43181C66-15CF-40AD-A670-2CFA4F7C9ECDQ34359304-387BC4BB-6618-4EAB-A307-AE81F0DFE07DQ34386081-0D72E012-C5E9-4EB1-A5FC-D356C88C3511Q34549328-4E9909A8-606B-4932-93A6-A6146B91068EQ34615270-7B1BF647-978A-44DB-B334-56BA83367772Q35584686-022FDF5C-75A4-4397-A8C9-42D5417A0FAEQ35779455-10EAEF4E-4075-4E3F-BB61-50FB750820D8Q35894352-CB3B4CB6-F803-400E-93AF-B372F59BC382Q35919934-31065C66-7CC3-47E4-AD6A-ECCE13A923EAQ36034178-8005E244-4842-4571-B638-2F4FA5EEA430Q36070180-48D41C97-D350-4D29-8421-487B0EA5A31DQ36490612-CA8C1964-7D5A-4119-9CD8-34A53F9C7336Q36851424-97D69103-C490-48AB-B5AF-AB10F2E177F9Q37677105-12A78CEA-B866-4C38-898E-BAB20BA84135Q37692869-95ABD158-FAC3-416E-B984-3370FE6E6E68Q37719619-4BB9F181-AAF3-4E02-86CF-CC7D1C620836Q37974976-033ABC0C-6657-4B17-BAF9-D1B2E20A9333Q38458166-D2B02B62-ED4A-463B-AEA3-D13114BB9494Q38605484-653F5CBE-0A33-4E12-B9E7-C88E43C26584Q38920892-65857403-1F6F-499F-A94C-A204D04515E3Q38967020-3C44BF3C-E6AC-49FE-8C17-E4DE6CA5A4D7Q39465288-40FDD2E6-154C-462D-9DB7-7B3393894442Q40130219-AF42D6FF-3A26-4716-8A4C-F6EF45387032Q40350715-DEDE10BD-5D6E-4DCF-9740-3F38B1A04C2DQ42374534-ED4BF7FD-1A3D-4464-8FB7-F85D9418A146Q49887562-EA6B2BEC-E096-4EA3-AFE0-6AF86D140C5EQ51132740-BB474599-8EEB-420D-A37E-F2EA150607FBQ51793495-448CF3DC-3D6C-4E5A-8851-EC2DE0897813Q52364992-764296FF-00E4-4F41-9C47-8B91FB10B438Q53412548-D1376199-B2BD-4CAF-9766-E772E7AC29AAQ55108469-04F86108-83CD-44AE-B7F2-5B8871E67780
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Polypharmacy in older adults with cancer.
@ast
Polypharmacy in older adults with cancer.
@en
type
label
Polypharmacy in older adults with cancer.
@ast
Polypharmacy in older adults with cancer.
@en
prefLabel
Polypharmacy in older adults with cancer.
@ast
Polypharmacy in older adults with cancer.
@en
P2093
P2860
P1433
P1476
Polypharmacy in older adults with cancer.
@en
P2093
Arti Hurria
Cary P Gross
Ronald J Maggiore
P2860
P304
P356
10.1634/THEONCOLOGIST.2009-0290
P577
2010-04-24T00:00:00Z